Product › Details

DRUGS, ORPHAN

	Next higher product group	pharmaceutical

Record changed: 2020-09-14

Picture EBD Group BIO-Europe 2020 Digital Event BEU2020 650x81

More documents for DRUGS, ORPHAN

[1] Inflazome Ltd.. (7/14/20). "Press Release: FDA Grants Orphan Drug Designation for Inflazome’s Inzomelid for the Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS)". Dublin, Cambridge & Brisbane....
[2] Freeline Therapeutics Ltd.. (5/4/20). "Press Release: Freeline Receives Orphan Drug Designation from the FDA for FLT190 for the Treatment of Fabry Disease". London....
[3] Evox Therapeutics Ltd.. (3/26/20). "Press Release: Evox Therapeutics and Takeda Sign Multi-target Rare Disease Collaboration"....
[4] CureVac AG. (2/26/20). "Press Release: CureVac Appoints Alan Kimura, MD, PhD as Head of the Newly Created Department “Rare Diseases”". Tübingen & Boston, MA....
[5] Audentes Therapeutics, Inc.. (12/2/19). "Press Release: Astellas Enters into Definitive Agreement to Acquire Audentes Therapeutics". Tokyo & San Francisco, CA....
[6] Merck KGaA. (11/20/19). "Press Release: Merck Announces Orphan Drug Designation for Investigational Therapy Tepotinib in Patients with NSCLC Harboring MET Gene Alterations 8Not intended for UK-based media]". Darmstadt....
[7] Adaptimmune Ltd.. (10/5/19). "Press Release: United States Orphan Drug Designation for Treatment of Soft Tissue Sarcomas Granted to SPEAR T-cells Targeting MAGE-A4". Philadeliphia, PA & Oxfordshire....
[8] Pharming Group N.V.. (8/13/19). "Press Release: Pharming Acquires Exclusive License to CDZ173, a Late Stage Drug for the Treatment of APDS". Leiden....
[9] Orchard Therapeutics Ltd.. (12/13/18). "Press Release: Orchard Therapeutics Announces the Build-out of New Gene Therapy Manufacturing Facility in California". Boston, MA & London....
[10] Centogene AG. (12/10/18). "Press Release: Centogene and Chiesi Germany Sign Strategic Alliance in Lysosomal Storage Disorders". Rostock & Hamburg....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

» top

Top News

Upcoming Events

Management Appointments

Financings & Acquisitions

Collaborations & Licensing

At Investor Conferences

Bio Regions & Life Sciences Clusters

Business Parks & Science Centres

Associations

Advertise

DRUGS, ORPHAN

More documents for DRUGS, ORPHAN